# Long-Term Lamivudine Therapy for Chronic Hepatitis B

> **NCT00120354** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 50 (—)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **PROCEDURE:** Blood Testing
- **PROCEDURE:** Percutaneous Liver Biopsy
- **PROCEDURE:** Lamivudine Therapy

## Key facts

- **NCT ID:** NCT00120354
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07-11
- **Primary completion:** —
- **Final completion:** 2007-03-31
- **Target enrollment:** 50 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120354, "Long-Term Lamivudine Therapy for Chronic Hepatitis B". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00120354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*